Sfoglia per Autore
Immunosuppression in multiple sclerosis: state of the art and future perspectives. In: A multidisciplinary approach to myelin diseases II
1994 L. Massacesi; MP. Amato; L. Amaducci
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program.
1994 M. Baldereschi; M. P. Amato; P. Nencini; G. Pracucci; A. Lippi; L. Amaducci; S. Gauthier; L. Beatty; P. Quiroga; G. Klassen
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up.
1995 Amato MP; Ponziani G; Pracucci G; Bracco L; Siracusa G; Amaducci L.
New therapies in multiple sclerosis: beta-interferon.
1996 M.P. AMATO
Placebo-controlled multicentre randomised trial of interferon-beta-1b in treatment of secondary progressive multiple sclerosis. Lancet.
1997 Amato, Mp
Cognitive impairment in multiple sclerosis: a longitudinal study
1998 Amato, M. P.; Ponziani, G
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
1998 Confavreux C; Hutchinson M; Hours MM; Cortinovis-Tourniaire P; Moreau T; MP Amato
Natural history of cognitive dysfunction in multiple sclerosis: a 4-year longitudinal study
1998 M. P. AMATO; G.PONZIANI
Le scale di valutazione clinica nella sclerosi multipla
1999 M.P. Amato
Diagnosi e tipo di decorso
1999 M.P. Amato
Le scale di valutazione clinica nella sclerosi multipla. In: Sclerosi multipla attualità e prospettive. Canal, Grezzi, Zaffaroni, Zibetti
1999 MP. Amato
Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. European Database for MUltiple Sclerosis. EVALUation of the EDMUS system.
1999 J. Grimaud; M. P. Amato; C. Confavreux
A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.
1999 M. P. Amato; G. Ponziani; M. L. Bartolozzi; G. Siracusa
Diagnosi e tipo di decorso. In: Sclerosi multipla stato dell’arte. Fieschi, Comi, Pozzilli .
1999 MP. Amato
Quantification of impairment in MS: discussion of the scales in use
1999 Amato, MP;Ponzani, G
Sclerosi multipla. Qualità della vita del paziente
2000 F. Rossi; C. Stefanile; L. Rossi; M.P. Amato
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis.
2000 C. Ballerini; D. Campani; G. Rombolà; B. Gran; B. Nacmias; M. P. Amato; G. Siracusa; L. Bartolozzi; S. Sorbi; L. Massacesi
A quality network model for the daily care of multiple sclerosis.
2000 L. D. Blumhardt; B. J. D. Vermeij; M. P. Amato; O. Andersen; G. Edan; O. Fernandez; M. Filippi; J. Haas; O. R. Hommes; P. Rieckmann
A prospective study on the prognosis of multiple sclerosis.
2000 M. P. Amato; G. Ponziani
Final anlysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS.
2001 Kappos l; Polman C; Pozzilli C; Thompson A; Beckmann K; Dahlke F; and The European Study Group in Interferon beta-1b in Secondary Progressive MS; MP Amato
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile